Comparison
2p13 2 Microdeletion Syndrome C4749460 vs 13q12 3 Microdeletion Syndrome C4750951
Clinical comparison between 2p13 2 Microdeletion Syndrome and 13q12 3 Microdeletion Syndrome for differential diagnosis and treatment planning.
2p13 2 Microdeletion Syndrome C4749460
A rare chromosomal condition where a small segment is missing from chromosome 2. Features vary based on which genes are affected. Care focuses on addressing specific symptoms.
13q12 3 Microdeletion Syndrome C4750951
A rare genetic condition where a small piece of chromosome 13 is missing. It can cause various developmental and medical concerns. Care is supportive and tailored to the individual's needs.
6 comparison axes
Onset
2p13 2 Microdeletion Syndrome C4749460
0-0
13q12 3 Microdeletion Syndrome C4750951
0-null
Onset patterns differ
Severity
2p13 2 Microdeletion Syndrome C4749460
severe
13q12 3 Microdeletion Syndrome C4750951
moderate
Different severity levels
Chronic
2p13 2 Microdeletion Syndrome C4749460
Chronic
13q12 3 Microdeletion Syndrome C4750951
Chronic
Differing course
Communicable
2p13 2 Microdeletion Syndrome C4749460
No
13q12 3 Microdeletion Syndrome C4750951
No
Different transmission
Body System
2p13 2 Microdeletion Syndrome C4749460
congenital
13q12 3 Microdeletion Syndrome C4750951
congenital
Same/different system
Category
2p13 2 Microdeletion Syndrome C4749460
rare-disease
13q12 3 Microdeletion Syndrome C4750951
genetic
Different category
Bottom line
2p13-2-microdeletion-syndrome-C4749460 and 13q12-3-microdeletion-syndrome-C4750951 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 2p13 2 Microdeletion Syndrome C4749460 | 13q12 3 Microdeletion Syndrome C4750951 | Discriminating power |
|---|---|---|---|
| Chromosomal locus | Missing segment involves chromosome 2 at 2p13.2. | Missing segment involves chromosome 13 at 13q12.3. | High |
| Clinical features | Features vary with affected genes; no definitive symptom list is established here. | Developmental and medical concerns may occur, but specific features are not established here. | Low |
| Severity label | Source classifies the condition as severe, though individual course varies. | Source classifies the condition as moderate, though individual course varies. | Moderate |
When to favor each condition
Choose 2p13 2 Microdeletion Syndrome C4749460 when
Genetic testing identifies a 2p13.2 deletion
The chromosomal locus distinguishes this condition from a 13q12.3 deletion.
High
A congenital chromosomal diagnosis is being classified
The source places this entity in the rare-disease category and labels severity severe.
Moderate
Symptom-focused congenital care is needed
Care is directed to the person's specific findings rather than a fixed syndrome checklist.
Moderate
Choose 13q12 3 Microdeletion Syndrome C4750951 when
Genetic testing identifies a 13q12.3 deletion
Confirmation of chromosome 13 involvement supports this diagnosis.
High
Developmental concerns need supportive planning
The source describes variable developmental and medical concerns with tailored support.
Moderate
Source severity is moderate rather than severe
This label may guide expectations, but it does not predict an individual's outcome.
Low
How key tests differ
| Test | 2p13 2 Microdeletion Syndrome C4749460 | 13q12 3 Microdeletion Syndrome C4750951 | Interpretation |
|---|---|---|---|
| Chromosomal microarray | May detect a deletion at 2p13.2. | May detect a deletion at 13q12.3. | Locus and gene content require laboratory and clinician interpretation. |
| Karyotype | A small deletion may not be visible. | A small deletion may not be visible. | A normal karyotype does not exclude either microdeletion. |
| Targeted genetic confirmation | Confirms chromosome 2 involvement when indicated. | Confirms chromosome 13 involvement when indicated. | Test choice depends on prior results; no cutoff is established here. |
Prognosis comparison
2p13 2 Microdeletion Syndrome C4749460
- Outcome
- Long-term outcome is not established; source severity is severe and course chronic.
- Factors
- Affected genes and individual findings may influence needs.
13q12 3 Microdeletion Syndrome C4750951
- Outcome
- Long-term outcome is not established; source severity is moderate and course chronic.
- Factors
- Individual developmental and medical concerns guide support.
Time frame: Congenital and chronic; exact onset data are incomplete.
Genetic result, clinical findings, and available supports; no mortality estimate is established.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental concerns | Possible but not specifically defined by the supplied data. Described as possible developmental concerns, without a fixed pattern. Assessment should be individualized; prevalence is not established. |
| Medical comorbidity | Depends on which genes are affected. Various medical concerns may occur. No complication is definitive from these descriptions alone. |
| Long-term support needs | Chronic, symptom-directed care may be needed. Chronic supportive care may be tailored to needs. Neither description establishes mortality or a uniform course. |
Patient education highlights
- HighDiagnosis
The specific chromosomal result, not symptoms alone, distinguishes these conditions.
- HighVariability
Features and severity can vary; source labels do not predict every person's course.
- MediumCare
Care is supportive and focused on identified developmental or medical needs.